Rejection, Transplant Completed Phase 4 Trials for Tacrolimus (DB00864)

Also known as: Graft Rejection / Transplant rejections / Transplant Rejection / Transplanted organ rejection (disorder) / Graft rejection (finding) / Complication of transplanted organ (disorder)

IndicationStatusPhase
DBCOND0030946 (Rejection, Transplant)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00807144Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney TransplantationPrevention
NCT00261820Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft RecipientsTreatment
NCT00369382Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant RecipientsPrevention
NCT00510913A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft FailurePrevention
NCT00895583Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant RecipientsPrevention